leadf
logo-loader

NA Proactive news snapshot: Canada Silver Cobalt Works, HealthLynked, GlobeX Data, DGTL Holdings UPDATE ...

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Newspapers and laptop
Your daily round-up from the world of Proactive

Canada Silver Cobalt Works Inc (CVE:CCW) (OTCMKTS:CCWOF), which is focused on the Cobalt Camp in the Gowganda district of Ontario, has announced a key step forward in its battery metals production aims, namely striking a deal with consultant SGS Canada Inc to build a Re-2OX pilot plant. Put simply, Canada Silver Cobalt Work's Re-2OX is a proprietary technology designed to efficiently extract cobalt and produce cobalt sulphate to specifications required by battery sector end-users. Today's agreement means SGS will carry out optimization tests and design and build the Stage 1 pilot plant at Lakefield, Ontario.

HealthLynked Corp (OTCQB:HLYK) announced that one of its early investors, Iconic Holdings, LLC, has agreed to convert all of its $1.3 million convertible debt, including principal and accrued interest, into 13.5 million HealthLynked common shares. The company said this will not only eliminate the interest payments but will also allow HealthLynked to obtain a bank line of credit at current low interest rates.

GlobeX Data Ltd (OTCQB:SWISF) (CSE:SWIS) announced that it has exercised its right to accelerate the expiry date of voting share purchase warrants issued to participants in the company's private placement that closed in May 2020. Management said it expects redemptions of the warrants to result in the issuance of 851,053 additional voting shares and cash proceeds to the company of C$110,636.89.

DGTL Holdings Inc (CVE:DGTL) (OTCQB:DGTHF) (FRA:A2QB0L) has announced a private placement on Friday for the second week in a row. This placement, worth C$1 million, is meant to accommodate subscribers that were unable to participate in the previously announced offering. On January 8, the company announced the closing of an C$883,615 placement, the second tranche of a larger offering. This time around, the company plans to issue up to roughly 2.7 million shares at a price of C$0.44 per share.

NexTech AR Solutions Corp (OTCQB:NEXCF) (NEO:NTAR) (FRA:N29) reported that it has signed a renewal agreement with Polycom valued at $470,000 initially for a six-month term. The company noted, however, that there is potential for additional revenue after the six months. “With these larger contracts renewing and our new focus on annual or multi-year enterprise sales, we are on the path to our stated goal of $50 million to $60 million in revenue for 2021,” NexTech AR Solutions CEO Evan Gappelberg said in a statement. 

Codebase Ventures Inc (CSE:CODE) (FRA:C5B) (OTCQB:BKLLF), a tech-centric investment company, revealed on Friday that it has inked a $2.5 million definitive agreement to acquire bit mining infrastructure in the US for long-term revenue generation. “Cryptocurrencies, including Bitcoin, have risen sharply in the last few months, and Codebase believes there is still long-term potential, as evidenced through recent brokerage analyst coverage, and mainstream investments,” Codebase President George Tsafalas said in a statement. Codebase’s investment will deliver the first phase of 9,450 Petahash per second worth of mining rigs fully hosted in the US. The company said it has the option for a second tranche of an equal number of mining rigs for a period of one year. 

Silvercorp Metals Inc (NSYEAMERICAN:SVM) (TSE:SVM) (FRA:S9Y) told investors on Friday it is set to achieve its annual production guidance for fiscal 2021 as the miner posted operating results for its third quarter to end-December, 2020.  The metals producer generates gold, silver, lead and zinc from two sites -  its Ying project and the GC mine - both in China. Consolidated silver production for the three months to December 31 last year was 1,676 ounces, down from 1,779 ounces in the same quarter in fiscal 2020.  Gold output for the period came in at 900 ounces (the same as in 3Q, 2020), while the company produced 17,111 pounds of lead, down from 20,044 pounds in the same quarter last year. It generated 8,673 pounds of zinc, up from 8,035 pounds in the same period of fiscal 2020.

ElectraMeccanica Vehicles Corp (NASDAQ:SOLO) is expanding the retail network for its flagship SOLO three-wheeled electric vehicle to three new West Coast locations, the company announced Friday. The new direct-to-consumer retailers will be located at The Village at Corte Madera, California; the Los Cerritos Center in Orange County, California; and La Encantada in Tucson, Arizona. These additions bring the company’s retail location count to a total of 13 across 10 major markets. Shoppers will be able to learn more about the SOLO, explore the vehicle and place reservations onsite. The new locations are slated to open in March, the company said.

Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCMKTS:NSPDF) (FRA:50N) said Friday that the third container of NATERA Plant Based Foods is in transit from Australia. In a statement, the company said it is continuing to expand distribution channels both regionally and nationally -- and this latest container provides the necessary inventory levels required to continue its push into food service and retail. The expanding NATERA Plant Based Food distribution network now includes Sysco Canada - BC Division, CANEX Foods, and Summit Specialty Foods. This diverse group of distributors provide access to hundreds of points of sales across Canada, servicing diverse demographics. 

Ideanomics Inc (NASDAQ:IDEX) (FRA:0V5) announced Friday, its Mobile Energy Global (MEG) division delivered 439 vehicles in December. The company said 356 were for the taxi/ride-hailing business and the remaining 83 for the rental-car business. All units, invoiced during the period from July through December 2020, were delivered, the company added in a statement.

Vuzix Corporation (NASDAQ:VUZI) (FRA:V7XN), a leading supplier of Smart Glasses, reported Friday that it appears to have achieved record revenue for its fourth quarter of 2020. However, the company noted in a statement that the preliminary results are unaudited. Vuzix said 4Q revenue increased more than 100% year-over-year to over $4 million, versus $1.96 million in the 2019 quarter. 

Ipsidy Inc (OTCQB:IDTY) CEO Phillip Kumnick told shareholders on Friday that the company is excited about the demand for its mobile biometric platform services “2020 was a challenging year for all of us, and I want to express our empathy and support for those who continue to suffer from the physical and financial effects of the pandemic,” Kumnick said in a statement announcing the date of the firm's annual general meeting. 2020 was also a period of significant transition for Ipsidy. I am proud of how the team at Ipsidy worked together to position our company for success in 2021," he added.

Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (CSE:LXX) has announced the closing of its previously announced underwritten public offering of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit. The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada. H.C. Wainwright & Co. acted as the sole book-running manager for the offering and is a non-related party to the company

Numinus Wellness Inc. (CVE:NUMI) said it has granted 1,975,000 incentive stock options to directors, officers and employees of the company, which are subject to regulatory approval. Of the 1,975,000 options granted, 1,800,000 were issued to directors and officers of Numinus, which have an exercise price of $1.16 per common share and are exercisable until January 13, 2023. The 175,000 options issued to employees were granted earlier this month, have an exercise price of $1.09 and are exercisable until January 5, 2023. The company's Stock Option Plan allows for the issuance of up to 10% of issued and outstanding share capital in the form of incentive stock options. As a result of the above grants, the company has 7,604,500 options issued, representing 4.74% of the issued and outstanding share capital. Numinus Wellness is a mental health and wellness company creating an ecosystem of solutions centred around safe, evidence-based, accessible psychedelic-assisted psychotherapy to help people heal and be well.

Versus Systems Inc. (CSE:VS) (OTCQB:VRSSF) (FRA:BMVA) has announced the pricing of its public offering of 1,280,000 units at US$7.50 per unit, for gross proceeds of US$9,600,000, before deducting underwriting discounts and commissions and other offering expenses. Each unit consists of one common share, one Unit A warrant and one Unit B warrant, each to purchase one common share at US$7.50 per share. All of the units are being offered by Versus. In addition, Versus has granted the underwriter a 30-day option to purchase up to an additional 192,000 common shares at the public offering price, less underwriting discounts and commissions.  The offering is expected to close on January 20, 2021, subject to the satisfaction of customary closing conditions. Lake Street Capital Markets, LLC is acting as sole book-running manager for the offering.

Litelink Technologies Inc. (CNSX:LLT) said it has granted 14.85 million incentive stock options to certain directors, officers, employees and consultants of the company. The options are exercisable at a price of 7 cents for a period of three years from the date of grant. The company's stock option plan governs these incentive options, as well as the terms and conditions of their exercise, in accordance with Canadian Securities Exchange policies.

Falcon Gold Corp (CVE:FG) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced December 2, 2020, and December 16, 2020, which sees the issue of 6,666,665 shares at a purchase price of 12 cents per share, together with 6,666,665 share purchase warrants with an exercise price of 20 cents for a three-year period with 22 placees.

AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) announced that it has rescheduled its investor conference call for 11.00am Eastern Time on Thursday, January 21, 2021, to discuss the recently announced commencement of the treatment of subjects with coronavirus (COVID-19)-induced chronic fatigue-like symptoms in the amended AMP-511 trial, recent accomplishments and upcoming milestones. Investors and other interested parties are invited to submit questions to management prior to the call's start via email to aim@crescendo-ir.com. The conference call will be available on the company’s website at https://aimimmuno.com/events-presentations/, or via telephone by dialing toll-free 877-407-8031 for US callers, or +1 201-689-8031 for international callers. For those unable to participate at that time, a replay of the call will be archived on the company’s website or can be accessed by dialing 877-481-4010 for US callers, or +1 919-882-2331 for international callers and entering the passcode 39447. The replay will be available for 90 days.

BioSig Technologies, Inc. (NASDAQ:BSGM), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, has announced that it will be presenting at the 26th Annual International Atrial Fibrillation Symposium, held virtually on January 29-31, 2021. Clinical observations collected with BioSig’s PURE EPTM System will be presented by G. Joseph Gallinghouse, M.D., Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, during Spotlight Session: Early Stage and Emerging New Technologies and Drugs in Cardiac EP on January 29, 2021, from 2.40pm-3.40pm ET. 

Media Central Capital Corporation announced Friday that it has negotiated various debt conversion agreements with five creditors of which four are arm's length parties to the corporation and one is a non-arm's length party as he is a director and/or officer of the corporation. Pursuant to the terms of the Debt Agreements, the corporation has agreed to issue an aggregate of 22,500,000 common shares to the creditors in exchange for the cancellation of 225,000 in debt owing to the parties. The debt shares issued pursuant to the debt conversion are subject to a statutory four-month hold period. Media Central Corporation Inc (CSE:FLYY) (FRA:3AT) is an alternative media company. 

Aurania Resources Ltd. (CVE:ARU) (OTCQB:AUIAF) (FRA:20Q) has announced that its chairman & CEO, Dr Keith Barron will present at NobleCon17 - Noble Capital Markets' Seventeenth Annual Investor Conference on Tuesday, January 19, 2021, at 1.30pm Eastern Standard Time. The conference is virtual, with no cost, obligation or restrictions to attend: www.noblecon17.com. A high-definition, video webcast of the presentation will be available a day or so after the live event on the company's website http://www.aurania.com/news/aurania-in-the-media/

OTC Markets Group Inc. (OTCQX:OTCM), the operator of financial markets for 11,000 U.S. and global securities, has announced that Atlantic Sapphire ASA (OTCQX:AASZF), an Oslo-listed company pioneering sustainable Bluehouse (landraised) salmon farming in Miami, Florida, USA, has qualified to trade on the OTCQX Best Market. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. "Congratulations to Atlantic Sapphire ASA on qualifying for the OTCQX Best Market," said Joe Coveney, vice president of Corporate Services at OTC Markets Group. "We are pleased to support innovative and entrepreneurial international companies seeking to strengthen transparency and to provide better access to disclosure and trading for U.S. investors. Cross-trading on OTCQX in the US will enable Atlantic Sapphire ASA, which is listed on the Oslo Børs, to diversify its investor base and to expand its global engagement even further." Johan E. Andreassen, chairman of Atlantic Sapphire ASA, said: "Since the first US harvest in September 2020, our Bluehouse Salmon has expanded its retail footprint to more than 1,000 locations, with more and more stores coming online as we continue to ramp-up production towards our 2031 target of 220,000t of harvest (about 1 Billion salmon meals each year). Atlantic Sapphire's groundbreaking, cutting-edge technology and aquaculture yield a healthy product that helps eliminates environmental concerns associated with conventional salmon farming. Bluehouse Salmon has a delicious mild flavor, is raised without antibiotics or pesticides, in a water source free of micro plastics. As the world's largest land-based salmon farming company with primary operation in the US, we're thrilled to be quoted on a US market and to further diversify our investor base as we expand operations."

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Silvercorp Metals Inc named herein, including the promotion by the Company of Silvercorp Metals Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

PharmaDrug pursuing Orphan Drug Designation with FDA to use DMT in kidney...

PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) CEO Daniel Cohen tells Proactive it has filed an application with the FDA to receive an orphan drug designation for the use of DMT in preventing kidney injuries in patients undergoing kidney transplants. Cohen says the group aims to unlock the potential...

1 hour, 32 minutes ago

13 min read